Peroxisome proliferator-activated receptor α mediates the adaptive response to fasting

Journal of Clinical Investigation

Volumn 103, Issue 11, 1999, Pages 1489-1498

  Kersten, Sander ^a   Seydoux, Josiane ^b   Peters, Jeffrey M ^c   Gonzalez, Frank J ^c   Desvergne, Béatrice ^a   Wahli, Walter ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; FATTY ACID BLOOD LEVEL; FATTY ACID OXIDATION; HYPOGLYCEMIA; HYPOTHERMIA; LIPID STORAGE; METABOLIC REGULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM;

EID: 0032699670     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI6223     Document Type: Article

References (51)

1. van den Berghe, G. 1991. The role of the liver in metabolic homeostasis: implications for inborn errors of metabolism. J. Inherit. Metab. Dis. 14:407-420.
2. Desvergne, B., IJpenberg, A., Devchand, P.R., and Wahli, W. 1998. The peroxisome proliferator-activated receptors at the cross-road of diet and hormonal signalling. J. Steroid Biochem. Mol. Biol. 65:65-74.
3. Gronemeyer, H., and Landet, V. 1995. Transcription factors 3: nuclear receptors. Protein Profile. 2:1173-1308.
4. Schoonjans, K., Staels, B., and Auwerx, J. 1996. Role of the peroxisome proliferator-acrivated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression. J. Lipid Res. 37:907-925.
5. Göttlicher, M., Widmark, E., Li, Q., and Gustafsson, J.A. 1992. Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorricoid receptor. Proc. Natl. Acad. Sci. USA. 89:4653-4657.
6. Keller, H., et al. 1993. Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers. Proc. Natl. Acad. Sci. USA. 90:2160-2164.
7. Forman, B.M., Chen, J., and Evans, R.M. 1997. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta. Proc. Natl. Acad. Sci. USA. 94:4312-4317.
8. Kliewer, S.A., et al. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma. Proc. Natl. Acad. Sci. USA. 94:4318-4323.
9. Krey, G., et al. 1997. Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. Mol. Endocrinol. 11:779-791.
10. Braissant, O., Foufelle, F., Scotto, C., Dauca, M., and Wahli, W. 1996. Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology. 137:354-366.
11. Tonronoz, P., Hu, E., and Spiegelman, B.M. 1994. Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-acrivated transcription factor. Cell 79:1147-1156.
12. Jiang, C., Ting, A.T., and Seed, B. 1998. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature. 391:79-82.
13. Ricore, M., Li, A.C., Willson, T.M., Kelly, C.J., and Glass, C.K. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Cell. 93:241-252.
14. Tontonoz, P., Nagy, L., Alvarez J.G., Thomazy, V.A., and Evans, R.M. 1998. PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidised LDL. Cell. 93:241-252.
15. Nagy, L., Tontonoz, P., Alvarez, J.G., Chen, H., and Evans, R.M. Oxidixed LDL regulates macrophage gene expression through ligand activation of PPARgamma. Cell. 93:229-240.
16. Lee, S.S., et al. 1995. Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol. Cell. Biol. 15:3012-3022.
17. Aoyama, T., et al. 1998. Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha). J. Biol. Chem. 273:5678-5684.
18. Peters, J.M., et al. 1997. Alterations in lipoprotein metabolism in peroxisome proliferator-activated receptor alpha-deficient mice. J. Biol. Chem. 272:27307-27312.
19. Motojima, K., Passilly, P., Peters, J.M., Gonzalez, F.J., and Latruffe, N. 1998 Expression of putative fatty acid transporter genes are regulated by peroxisome proliferator-activated receptor alpha and gamma activators in a tissue- and inducer-specific manner. J. Biol. Chem. 273:16710-16714.
20. Djouadi, F., et al. 1998. A gender-related defect in lipid metabolism and glucose homeostasis in peroxisome proliferator-activated receptor alpha-deficient mice. J. Clin. Invest. 102:1083-1091.
21. Costet, P., et al. 1998. Peroxisome proliferator-activated receptor alpha-isoform deficiency leads to progressive dyslipidemia with sexually dimorphic obesity and steatosis. J. Biol. Clin. 273:29577-29585.
22. Lavery, D.J., Lopez-Molina, L., Fleury-Olela, F., and Schibler, U. 1997. Selective amplification via biotin- and restriction-mediated enrichment (SABRE), a novel selective amplification procedure for defection of differentially expressed mRNAs. Proc. Natl. Acad. Sci. USA. 94:6831-6836.
23. Weir, J.B. 1949. New method for calculating metabolic rate with special reference to protein metabolism. J. Physiol. (Lond) 109:1-9.
24. Van Steenbergen, W., and Lanckmans, S. 1995. Liver disturbances in obesity and diabetes mellitus. Int. J. Obes. Relat. Metab. Disord. 19:S27-S36.
25. Surwit, R.S., et al. 1995. Differential effects of fat and sucrose on the development of obesity and diabetes in C57BL/6J and A/J mice. Metabolism. 44:645-651.
26. Rebuffe-Scrive, M., Surwit, R.S, Feinglos, M.N, Kuhn, C.M., and Rodin, J. 1993. Regional fat distribution and metabolism in a new mouse model (C57BL/6J) of non-insulin-dependent diabetes mellitus. Metabolism. 42:1405-1409. Nature 1998 Jan 1;391(6662):82-86.
27. Rebuffe-Scrive, M., Surwit, R.S, Feinglos, M.N, Kuhn, C.M., and Rodin, J. 1993. Regional fat distribution and metabolism in a new mouse model (C57BL/6J) of non-insulin-dependent diabetes mellitus. Metabolism. 42:1405-1409. Nature 1998 Jan 1;391(6662):82-86.
28. Doherty, J.F., Adam, E.J., Griffin, G.E., and Golden, M.H. 1992. Ultrasonographic assessment of the extent of hepatic steatosis in severe malnutrition. Arch. Dis. Child. 67:1348-1352.
29. Reif, S., et al. 1993. Perinatal food restricrion in rats reduces the content but not concentration of liver extracellular matrix proteins. J. Nutr. 123:811-816.
30. Yasuhara, M., et al. 1991. Induction of fatty liver by fasting in suncus. J. Lipid. ReS. 32:887-891.
31. Martin, G., Schoonjans, K., Lefebvre, A.M., Staels, B., and Auwerx, J. 1997. Coordinate regulation of the expression of the fatty acid transport protein and acyl-CoA synthetase genes by PPARα and PPARγ activators. J. Biol. Chem. 272:28210-28217.
32. Webb, G.P., Jagot, S.A., and Jakobson, M.E. 1982. Fasting-induced torpor in Mus musculus and its implications in the use of murine models for human obesity studies. Comp. Biochem. Physiol. A. Mol. Integr. Physiol. 72:211-219.
33. McGarry, J.D., and Brown, N.F. 1997. The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis. Eur. J. Biochem. 244:1-14.
34. Lemberger, T., et al. 1996. Expression of the peroxisome proliferator-activated receptor alpha gene is stimulated by stress and follows a diurnal rhythm. J. Biol. Chem. 279:1764-1769.
35. Ren, B., Thelen, A.P., Peters, J.M., Gonzalez, F.J., and Jump, D.B. 1997. Polyunsaturated fatty acid suppression of hepatic fatty acid synthase and S14 gene expression does not require peroxisome proliferator-activated receptor alpha. J. Biol. Chem. 272:26827-26832.
36. Karan, M.B., van Birgelen, A., Deslypere, J.P., Penders, M., and van Staveren, W.A. 1991. Biological markers of dietary intake, with emphasis on fatty acids. Ann. Nutr. Metab. 35:249-252.
37. Meunier-Durmort, C., Poirier, H., Niot, I., Forest, C., and Besnard, P. 1996. Up-regulation of the expression of the gene for liver fatty acid-binding protein by long-chain fatty acids. Biochem. J. 319:483-487.
38. Poirier, H., Braissant, O., Niot, I., Wahli, W., and Besnard, P. 1997. 9-cis-retinoic acid enhances fatty acid-induced expression of the liver fatty acid-binding protein gene. FEBS Lett. 412:480-484.
39. Tontonoz, P., Hu, E., Devine, J., Beale, E.G., and Spiegelman, B.M. 1995. PPAR gamma 2 regulates adipose expression of the phosphoenolpyruvate carboxykinase gene. Mol. Cell. Biol. 15:351-357.
40. Arias, G., Asins, G., Hegardt, F.G., and Serra, D. 1997. The effect of fasting/refeeding and insulin treatment on the expression of the regulatory genes of ketogenesis in intestine and liver of suckling rats. Arch. Biochem. Biophys. 340:287-298.
41. Arias, G., Asins, G., Hegardt, F.G., and Serra, D. 1998. The effect of dexamethasone treatment on the expression of the regulatory genes of ketogenesis in intestine and liver of suckling rats Mol. Cell. Biochem. 178:325-333.
42. Klemm, D.J., et al. 1998. Insulin stimulates cAMP-response element binding protein activity in HepG2 and 3T3-L1 cell lines. J. Biol. Chem. 273:917-923.
43. Kaikaus, R.M., Chan, W.K., Ortiz de Montellano, P.R., and Bass, N.M. 1993. Mechanisms of regulation of liver fatty acid-binding protein. Mol. Cell. Biochem. 123:93-100.
44. Juge-Aubry, C., et al. 1997. DNA binding properties of peroxisome proliferator-activated receptor subtypes on various natural peroxisome proliferator response elements. Importance of the 5′-flanking region. J. Biol. Chem. 272:25252-25259.
45. Sugiyama, T., Scott, D.K., Wang, J.C., and Granner, D.K. 1998. Structural requirements of the glucocorticoid and retinoic acid response units in the phosphoenolpyruvate carboxykinase gene promoter. Mol. Endocrinol. 12:1487-1498.
46. Kelly, L.J., et al. 1998. Peroxisome proliferator-activated receptors gamma and alpha mediate in vivo regulation of uncoupling protein (UCP-1, UCP-2, UCP-3) gene expression. Endocrinology. 139:4920-4927.
47. Larrouy, D., et al. 1997. Kupffer cells are a dominant site of uncoupling protein 2 expression in rat liver. Biochem. Biophys. Res. Commun. 235:760-764.
48. Stanley, C.A. 1987. New genetic defects in mitochondrial fatty acid oxidation and carnitine deficiency. Adv. Pediatr. 34:59-88.
49. Ratheiser, K., et al. 1991. Inhibition by etomoxir of carnitine palmitoyltransferase I reduces hepatic glucose production and plasma lipids in non-insulin-dependent diabetes mellitus. Metabolism. 40:1185-1190.
50. Reaven, G.M., Chang, H., and Hoffman, B.B. 1988. Additive hypoglycemic effects of drugs that modify free-fatty acid metabolism by different mechanisms in rats with streptozocin-induced diabetes. Diabetes. 37:28-32.
51. Bryson, J.M., Cooney, G.J., Wensley, V.R., Phuyal, J.L., and Caterson, I.D. 1996. The effects of the inhibition of fatty acid oxidation on pyruvate dehydrogenase complex activity in tissues of lean and obese mice. Int. J. Obes. Relat. Metab. Disord. 20:738-744.